Cathie Wood Gilead Sciences, Inc. Transaction History

Ark Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 07, 2018	SELL	$71.28 - $78.92 $2.06 Million - $2.28 Million	-28,946 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$64.88 - $75.68 $488,481 - $569,794	-7,529 Reduced 20.64%	28,946 $2.05 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $932,424 - $1.14 Million	12,801 Added 54.07%	36,475 $2.75 Million
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $1.24 Million - $1.45 Million	17,369 Added 275.48%	23,674 $1.7 Million
Q3 2017 Nov 09, 2017	BUY	$72.11 - $85.47 $454,653 - $538,888	6,305	6,305 $511,000

1,923

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.